![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ZNF573 |
Gene summary for ZNF573 |
![]() |
Gene information | Species | Human | Gene symbol | ZNF573 | Gene ID | 126231 |
Gene name | zinc finger protein 573 | |
Gene Alias | ZNF573 | |
Cytomap | 19q13.12 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | Q86YE8 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
126231 | ZNF573 | PTC01 | Human | Thyroid | PTC | 4.47e-03 | 6.91e-02 | 0.1899 |
126231 | ZNF573 | PTC05 | Human | Thyroid | PTC | 1.63e-04 | 1.57e-01 | 0.2065 |
126231 | ZNF573 | PTC06 | Human | Thyroid | PTC | 4.47e-09 | 1.00e-01 | 0.2057 |
126231 | ZNF573 | PTC07 | Human | Thyroid | PTC | 8.73e-10 | 8.68e-02 | 0.2044 |
126231 | ZNF573 | ATC12 | Human | Thyroid | ATC | 2.74e-05 | 4.69e-02 | 0.34 |
126231 | ZNF573 | ATC13 | Human | Thyroid | ATC | 4.30e-51 | 8.53e-01 | 0.34 |
126231 | ZNF573 | ATC4 | Human | Thyroid | ATC | 6.95e-07 | 5.60e-02 | 0.34 |
126231 | ZNF573 | ATC5 | Human | Thyroid | ATC | 1.76e-54 | 9.02e-01 | 0.34 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Thyroid | ![]() | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis | ||
PTC: Papillary thyroid cancer |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ZNF573 | SNV | Missense_Mutation | c.1073N>C | p.Tyr358Ser | p.Y358S | Q86YE8 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-A8-A09Z-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
ZNF573 | SNV | Missense_Mutation | rs763194237 | c.1124N>A | p.Arg375Gln | p.R375Q | Q86YE8 | protein_coding | tolerated(0.88) | benign(0.013) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
ZNF573 | SNV | Missense_Mutation | c.1579G>A | p.Glu527Lys | p.E527K | Q86YE8 | protein_coding | tolerated(0.18) | possibly_damaging(0.671) | TCGA-BI-A0VS-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
ZNF573 | SNV | Missense_Mutation | c.1459N>G | p.Gln487Glu | p.Q487E | Q86YE8 | protein_coding | tolerated(0.41) | benign(0.431) | TCGA-C5-A1BI-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Chemotherapy | cisplatin | SD | |
ZNF573 | SNV | Missense_Mutation | c.1039N>G | p.Leu347Val | p.L347V | Q86YE8 | protein_coding | tolerated(0.83) | probably_damaging(0.932) | TCGA-DR-A0ZM-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Unspecific | Cisplatin | SD | |
ZNF573 | SNV | Missense_Mutation | c.1612N>C | p.Tyr538His | p.Y538H | Q86YE8 | protein_coding | tolerated(0.42) | benign(0.435) | TCGA-AA-3966-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
ZNF573 | SNV | Missense_Mutation | novel | c.1907A>C | p.Lys636Thr | p.K636T | Q86YE8 | protein_coding | deleterious(0.01) | probably_damaging(0.941) | TCGA-AA-3984-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ZNF573 | SNV | Missense_Mutation | c.1049G>T | p.Arg350Ile | p.R350I | Q86YE8 | protein_coding | deleterious(0.02) | possibly_damaging(0.831) | TCGA-AA-A00N-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
ZNF573 | SNV | Missense_Mutation | c.760G>A | p.Ala254Thr | p.A254T | Q86YE8 | protein_coding | tolerated(0.48) | benign(0.113) | TCGA-AD-5900-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
ZNF573 | SNV | Missense_Mutation | c.193G>T | p.Val65Leu | p.V65L | Q86YE8 | protein_coding | tolerated(0.75) | benign(0.006) | TCGA-AY-6197-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |